3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
6
Leukemia, Myelomonocytic, Chronic
3
Neoplasms
2
Myeloproliferative Disorders
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
13
Magnetic Resonance Spectroscopy
11
Cisplatin
9
Specimen Handling
8
pembrolizumab
6
Radiation
5
Mitomycin
5
Fluorouracil
5
Cystoscopy
5
enfortumab vedotin
4
Transurethral Resection of Bladder
4
Radiotherapy
4
Cystectomy
4
durvalumab
3
dehydroftorafur
3
avelumab
3
Platinum
3
Nivolumab
3
Mitozytrex
3
Carboplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tremelimumab
2
erdafitinib
2
atezolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Paclitaxel
2
Immunoglobulin G
2
Docetaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Azacitidine
×
30 days
×
Clear all
No trials found.